Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety.
Hirsh
J
J
Dalen
J E
JE
Deykin
D
D
Poller
L
L
D001777:Blood Coagulation / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D016903:Drug Monitoring; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced; D013924:Thrombophlebitis / Q000188:drug therapy
D006495:Heparin, Low-Molecular-Weight; D006493:Heparin